Background Bariatric surgery is an effective treatment for severe obesity. It also ameliorates diabetes independently of weight loss through mechanisms that are not fully understood. In this study, we investigated the levels of GH, IGF-1 and IGF-binding protein (IGFBP-2) after gastric sleeve surgery in healthy obese individuals.
Method This study was conducted in 33 obese (BMI >38.3) healthy male subjects aged 25 to 50 years undergoing sleeve gastrectomy. GH, IGF-1 and IGFBP-2 levels were evaluated by ELISA at baseline and 6-12 months after surgery. Other parameters, such as glucose, BMI, insulin, HOMA-IR and lipid profile, were also investigated.
Results Systemic GH (12.32 vs. 50.97 pg/mL, p < 0.001) and IGFBP-2 levels (51.86 vs. 68.81 pg/mL, p < 0.001) were elevated after bariatric surgery. There was no change in IGF-1 level from before to after surgery. BMI (52.18 vs. 40.11, p = 0.001), insulin (19.35 vs. 8.80 mIU/L, p < 0.001) and HOMA-IR index (6.48 to 2.52, p < 0.001) were reduced after surgery. Lipid profile analysis revealed that total cholesterol (4.26 vs. 5.12 mmol/L, p < 0.001) and high-density lipoprotein (HDL) (0.90 to 1.55 mmol/L, p < 0.001) were increased, while triglycerides were decreased, after surgery (1.62 vs. 1.05 mmol/L p < 0.001). GH, IGF-1, and IGFBP-2 were not correlated with insulin or lipid parameters.
Conclusions Our study suggests that improved circulating GH and IGFBP-2 levels may mediate the beneficial effects of gastric sleeve surgery in improving insulin sensitivity and reducing insulin demand.
Figure 1
Loading...
On 14 May, 2020
On 29 Apr, 2020
On 28 Apr, 2020
On 17 Dec, 2019
Posted 24 Mar, 2020
On 30 Mar, 2020
Received 28 Mar, 2020
Received 23 Mar, 2020
On 22 Mar, 2020
On 20 Mar, 2020
On 19 Mar, 2020
Invitations sent on 19 Mar, 2020
On 18 Mar, 2020
On 18 Mar, 2020
On 06 Feb, 2020
Received 25 Jan, 2020
Received 17 Jan, 2020
On 02 Jan, 2020
Invitations sent on 30 Dec, 2019
On 30 Dec, 2019
On 17 Dec, 2019
On 16 Dec, 2019
On 16 Dec, 2019
On 16 Dec, 2019
On 14 May, 2020
On 29 Apr, 2020
On 28 Apr, 2020
On 17 Dec, 2019
Posted 24 Mar, 2020
On 30 Mar, 2020
Received 28 Mar, 2020
Received 23 Mar, 2020
On 22 Mar, 2020
On 20 Mar, 2020
On 19 Mar, 2020
Invitations sent on 19 Mar, 2020
On 18 Mar, 2020
On 18 Mar, 2020
On 06 Feb, 2020
Received 25 Jan, 2020
Received 17 Jan, 2020
On 02 Jan, 2020
Invitations sent on 30 Dec, 2019
On 30 Dec, 2019
On 17 Dec, 2019
On 16 Dec, 2019
On 16 Dec, 2019
On 16 Dec, 2019
Background Bariatric surgery is an effective treatment for severe obesity. It also ameliorates diabetes independently of weight loss through mechanisms that are not fully understood. In this study, we investigated the levels of GH, IGF-1 and IGF-binding protein (IGFBP-2) after gastric sleeve surgery in healthy obese individuals.
Method This study was conducted in 33 obese (BMI >38.3) healthy male subjects aged 25 to 50 years undergoing sleeve gastrectomy. GH, IGF-1 and IGFBP-2 levels were evaluated by ELISA at baseline and 6-12 months after surgery. Other parameters, such as glucose, BMI, insulin, HOMA-IR and lipid profile, were also investigated.
Results Systemic GH (12.32 vs. 50.97 pg/mL, p < 0.001) and IGFBP-2 levels (51.86 vs. 68.81 pg/mL, p < 0.001) were elevated after bariatric surgery. There was no change in IGF-1 level from before to after surgery. BMI (52.18 vs. 40.11, p = 0.001), insulin (19.35 vs. 8.80 mIU/L, p < 0.001) and HOMA-IR index (6.48 to 2.52, p < 0.001) were reduced after surgery. Lipid profile analysis revealed that total cholesterol (4.26 vs. 5.12 mmol/L, p < 0.001) and high-density lipoprotein (HDL) (0.90 to 1.55 mmol/L, p < 0.001) were increased, while triglycerides were decreased, after surgery (1.62 vs. 1.05 mmol/L p < 0.001). GH, IGF-1, and IGFBP-2 were not correlated with insulin or lipid parameters.
Conclusions Our study suggests that improved circulating GH and IGFBP-2 levels may mediate the beneficial effects of gastric sleeve surgery in improving insulin sensitivity and reducing insulin demand.
Figure 1
Loading...